Plus, the FDA granted emergency use authorization for Abbott Laboratories’ COVID-19 antibodies test, oil is higher after Saudi Arabia said it would cut production by an additional 1 million barrels per day, and Constellation Brands got a downgrade from MKM Partners.
Read MoreHaving a contrarian temperament generally means doing the opposite of what most people would do. It’s a mindset that I’ve found very useful as an investor, because while most people tend to flock to stocks that are at or near all-time highs, I’m able to find excellent long-term opportunities at much lower, bargain-level prices. It’s […]
Read MoreTrade Setup Buy Target $5.79 Sell Target $7.14 Five Point Holdings, LLC, through its subsidiary, Five Point Operating Company, LP, plans, develops, and owns mixed-use communities in California, the United States. The company operates through four segments: Newhall, San Francisco, Great Park, and Commercial.
Read MoreTrade Setup Buy Target $7.32 Sell Target $9.63 Pfenex Inc., a clinical-stage development and licensing biotechnology company, focuses on developing protein therapies for unmet patient needs. Its lead product candidate include PF708, a therapeutic equivalent drug candidate to Forteo (teriparatide) for the treatment of osteoporosis.
Read MoreOver the last month and a half, the market has rebounded pretty strongly off of its bear market lows. Just as the slide that started in February as nations across the globe began imposing economic shutdowns and shelter-in-place orders to slow the COVID-19 infection rate affected just about every sector of the economy, so to […]
Read MoreBuy Price: $14.75 or better Sell Price: TradersPro Sell Signal Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies using protein design technology. The company’s lead product candidate is NL-201, a computationally-designed de novo protein therapeutic for the treatment of IL-2/IL-15 cancer immunotherapy. It also engages in research activities for the treatment of autoimmunity and allergy.
Read MorePlus, Sorrento Therapeutics is partnering with New York’s Mount Sinai on developing a antibody cocktail to shield health care workers and other front-line workers from the coronavirus, Tesla is resuming production at its Fremont, CA plant, and Disney shares got a boost from tickets selling out within minutes for the reopening of its Shanghai Disneyland park.
Read MoreThe worst may be over for these 2 casino stocks.
Read MoreWhile much of the market has been crushed by the coronavirus pandemic, these 6 stocks have been climbing higher.
Read MoreSeveral experts have a warning smart investors may want to heed.
Read MoreThis stock could portend what’s to come for the world market.
Read MoreThe long-term bear is bullish on these 2 well-known stocks in a world of remote everything amid the coronavirus crisis.
Read MoreTrade Setup Buy Target $0.78 Sell Target $0.98 Castlight Health, Inc. provides health navigation solutions for employers and health plan customers in education, manufacturing, retail, technology, and government industries in the United States. It provides Care Guidance Navigator that enables users to make care decisions and navigate the employer-sponsored healthcare benefit programs
Read MoreBuy Price: $96 or better Sell Price: TradersPro Sell Signal Axsome Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing novel therapies for central nervous system (CNS) disorders in the United States. Its product pipeline includes AXS-05, which is in the phase III clinical trial for the treatment resistant depression and depressive disorders; and […]
Read MorePlus, stocks are higher on hopes for trade talks between the U.S. and China, weekly jobless claims came in at 3.17 million, luxury department store Neiman Marcus filed for Chapter 11, and Tesla has temporarily halted production at its Shanghai plant.
Read More